Grace Therapeutics (GRCE) Stock Chart & Stock Price History $3.22 -0.04 (-1.23%) As of 03:59 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Grace Therapeutics Stock Price Performance The Grace Therapeutics (GRCE) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 13.90%. In the past month, the stock has increased 3.87%, reflecting recent market activity. As of the latest close, Grace Therapeutics traded at $3.26 with a market cap of $45.08 million and volume of 45,552 shares. Receive GRCE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Grace Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+0.63%1 Month Performance+3.87%3 Month Performance+12.98%Year-To-Date Performance-13.90% GRCE Stock Chart for Thursday, September, 11, 2025 GRCE Chart by TradingView Grace Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/11/2025$3.26$3.22-1.23%$3.30$3.18185,083 shs$44.53 million09/10/2025$3.26$3.26$3.28$3.2445,552 shs$45.08 million09/09/2025$3.24$3.26+0.62%$3.30$3.2294,550 shs$45.09 million09/08/2025$3.20$3.24+1.25%$3.34$3.2284,724 shs$44.81 million09/05/2025$3.06$3.20+4.58%$3.30$3.06257,036 shs$44.26 million09/04/2025$2.97$3.06+3.03%$3.13$2.9579,451 shs$42.32 million09/03/2025$2.99$2.97-0.67%$2.99$2.9328,566 shs$41.08 million09/02/2025$3.03$2.99-1.32%$3.05$2.9842,344 shs$41.35 million09/01/2025$3.03$3.03$3.06$2.9162,000 shs$41.90 million08/29/2025$2.99$3.03+1.34%$3.06$2.9162,000 shs$41.90 million Get the Latest News and Ratings for GRCE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Grace Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/28/2025$3.07$2.99-2.61%$3.12$2.91110,197 shs$41.35 million08/27/2025$3.21$3.07-4.36%$3.29$3.03259,027 shs$42.46 million08/26/2025$3.25$3.21-1.23%$3.32$3.1529,575 shs$44.39 million08/25/2025$3.25$3.25$3.39$3.2173,456 shs$44.95 million08/22/2025$3.30$3.25-1.52%$3.34$3.2365,912 shs$44.95 million08/21/2025$3.27$3.30+0.92%$3.40$3.23194,479 shs$45.64 million08/20/2025$3.29$3.27-0.61%$3.27$3.1750,826 shs$45.22 million08/19/2025$3.23$3.29+1.86%$3.30$3.2167,964 shs$45.50 million08/18/2025$3.26$3.23-0.92%$3.34$3.2365,257 shs$44.67 million08/15/2025$3.08$3.26+5.84%$3.30$3.1378,672 shs$45.09 million08/14/2025$3.28$3.08-6.10%$3.40$2.93185,902 shs$42.60 million08/13/2025$3.20$3.28+2.50%$3.40$3.15131,997 shs$45.36 million08/12/2025$3.10$3.20+3.23%$3.33$3.09103,433 shs$44.26 million08/11/2025$3.22$3.10-3.73%$3.32$3.0775,478 shs$42.87 million Related Companies Black Diamond Therapeutics Stock Price Chart Seres Therapeutics Stock Price Chart Nuvectis Pharma Stock Price Chart FitLife Brands Stock Price Chart Kyverna Therapeutics Stock Price Chart Greenwich LifeSciences Stock Price Chart Eledon Pharmaceuticals Stock Price Chart Citius Oncology Stock Price Chart Milestone Pharmaceuticals Stock Price Chart Molecular Partners Stock Price Chart Receive GRCE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Grace Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GRCE) was last updated on 9/11/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grace Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grace Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GRCE Stock Alerts